臺灣核心實作指引(TW Core IG)
0.3.2 - Trial Use

This page is part of the 臺灣核心實作指引(TW Core IG) (v0.3.2: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

CodeSystem: 臺灣食藥署藥品藥理治療分類ATC碼

Official URL: https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw Version: 2022-10-24
Active as of 2014-09-19 Computable Name: TWMedcationATC

Copyright/Legal: 衛生福利部食品藥物管理署

臺灣食藥署藥品藥理治療分類ATC碼，參照至藥品藥理治療分類ATC碼資料集，資料提供單位：衛生福利部食品藥物管理署。

此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼，為符合國內代碼使用，故將未被定義之代碼另外呈現。

因原始資料無代碼版本資訊，故使用其「更新日期」作為版本資訊。

This Code system is referenced in the content logical definition of the following value sets:

  • This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Generated Narrative: CodeSystem medcation-atc-tw

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
effectiveDate effectiveDate http://hl7.org/fhir/concept-properties#effectiveDate dateTime 生效日期
status status http://hl7.org/fhir/concept-properties#status code 狀態

Concepts

This case-sensitive code system https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw defines the following codes:

CodeDisplayeffectiveDatestatus
A10BD27 metformin, linagliptin and empagliflozin 2014-09-19 active
A16AB22 avalglucosidase alfa 2014-09-19 active
C03DA05 finerenone 2014-09-19 active
D11AH08 abrocitinib 2014-09-19 active
G04BD14 imidafenacin 2014-09-19 active
H01AC08 somatrogon 2014-09-19 active
H01BA06 argipressin 2014-09-19 active
J05AB04 ribavirin 2014-09-19 active
J05AX11 elvitegravir 2014-09-19 active
J05AX12 dolutegravir 2014-09-19 active
J05AX67 ombitasvir, paritaprevir and ritonavir 2014-09-19 active
J05AX68 elbasvir and grazoprevir 2014-09-19 active
L01EX22 selpercatinib 2014-09-19 active
L01FX18 amivantamab 2014-09-19 active
L01XE01 imatinib 2014-09-19 active
L01XE03 erlotinib 2014-09-19 active
L01XE06 dasatinib 2014-09-19 active
L01XE10 everolimus 2014-09-19 active
L01XE11 pazopanib 2014-09-19 active
L01XE31 nintedanib 2014-09-19 active
L01XX14 tretinoin 2014-09-19 active
L01XX17 topotecan 2014-09-19 active
L01XX19 irinotecan 2014-09-19 active
L01XX32 bortezomib 2014-09-19 active
L01XX73 sotorasib 2014-09-19 active
L04AA52 ofatumumab 2014-09-19 active
N05CM21 lemborexant 2014-09-19 active